Metropolitan Life Insurance Company (MetLife)’s Utah Medical Products UTMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-172	Closed	-$12.2K	–	2019
2024 Q1	$12.2K	Sell	172 -77	-31%	-$5.78K	﹤0.01%	2059
2023 Q4	$21K	Hold	249	–	–	﹤0.01%	1903
2023 Q3	$21.4K	Buy	249 +73	+41%	+$6.74K	﹤0.01%	1861
2023 Q2	$16.4K	Hold	176	–	–	﹤0.01%	2035
2023 Q1	$16.7K	Sell	176 -65	-27%	-$5.97K	﹤0.01%	1975
2022 Q4	$24.2K	Hold	241	–	–	﹤0.01%	1906
2022 Q3	$20.6K	Hold	241	–	–	﹤0.01%	2017
2022 Q2	$20.7K	Hold	241	–	–	﹤0.01%	2036
2022 Q1	$21.7K	Sell	241 -737	-75%	-$67.8K	﹤0.01%	2053
2021 Q4	$97.8K	Hold	978	–	–	﹤0.01%	2498
2021 Q3	$90.8K	Buy	+978	New	+$86.4K	﹤0.01%	2579
2021 Q1	–	Sell	-1,378	Closed	-$116K	–	2600
2020 Q4	$116K	Hold	1,378	–	–	﹤0.01%	2283
2020 Q3	$110K	Hold	1,378	–	–	﹤0.01%	2162
2020 Q2	$122K	Hold	1,378	–	–	﹤0.01%	2131
2020 Q1	$130K	Hold	1,378	–	–	﹤0.01%	1873
2019 Q4	$149K	Hold	1,378	–	–	﹤0.01%	2104
2019 Q3	$132K	Hold	1,378	–	–	﹤0.01%	2146
2019 Q2	$132K	Hold	1,378	–	–	﹤0.01%	2164
2019 Q1	$122K	Sell	1,378 -159	-10%	-$14K	﹤0.01%	2205
2018 Q4	$128K	Buy	1,537 +189	+14%	+$16.6K	﹤0.01%	2112
2018 Q3	$127K	Hold	1,348	–	–	﹤0.01%	2308
2018 Q2	$148K	Hold	1,348	–	–	﹤0.01%	2121
2018 Q1	$133K	Buy	1,348 +29	+2%	+$2.59K	﹤0.01%	2141
2017 Q4	$107K	Sell	1,319 -1,531	-54%	-$120K	﹤0.01%	2273
2017 Q3	$210K	Sell	2,850 -203	-7%	-$14.6K	﹤0.01%	2245
2017 Q2	$221K	Hold	3,053	–	–	﹤0.01%	2278
2017 Q1	$190K	Hold	3,053	–	–	﹤0.01%	2298
2016 Q4	$222K	Hold	3,053	–	–	﹤0.01%	2296
2016 Q3	$183K	Hold	3,053	–	–	﹤0.01%	2390
2016 Q2	$192K	Hold	3,053	–	–	﹤0.01%	2342
2016 Q1	$191K	Hold	3,053	–	–	﹤0.01%	2205
2015 Q4	$179K	Hold	3,053	–	–	﹤0.01%	2330
2015 Q3	$164K	Sell	3,053 -271	-8%	-$14.8K	﹤0.01%	2415
2015 Q2	$198K	Buy	3,324 +179	+6%	+$10.1K	﹤0.01%	2406
2015 Q1	$188K	Hold	3,145	–	–	﹤0.01%	2088
2014 Q4	$189K	Hold	3,145	–	–	﹤0.01%	2452
2014 Q3	$153K	Hold	3,145	–	–	﹤0.01%	2544
2014 Q2	$162K	Buy	3,145 +152	+5%	+$7.8K	﹤0.01%	2628
2014 Q1	$173K	Buy	+2,993	New	+$163K	﹤0.01%	2554
2013 Q4	–	Sell	-2,953	Closed	-$176K	–	2760
2013 Q3	$176K	Hold	2,953	–	–	﹤0.01%	2515
2013 Q2	$160K	Buy	+2,953	New	+$139K	﹤0.01%	2509

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s UTMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Utah Medical Products (UTMD) in Q2 2024, closing a stake of 172 shares — an estimated $12.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in UTMD in Q2 2013 and held it in 41 quarters. The position peaked at $222K in Q4 2016. 100 funds tracked by Wall St. Rank hold UTMD as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Utah Medical Products position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 172 Utah Medical Products shares in Q2 2024, an estimated $12.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Utah Medical Products in Q2 2013 and held it in 41 quarters.
Metropolitan Life Insurance Company (MetLife)'s Utah Medical Products position peaked at $222K in Q4 2016.
100 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.